lobbying_activities: 3006973

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3006973	cf662790-b8ab-45e3-ae2d-d5d3842e55f9	Q2	KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)	401105192	CVS HEALTH	2023	second_quarter	PHA	Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2023-07-17T12:56:34-04:00